Who Exports Allopurinol from India — 223 Suppliers Behind a $492.9M Market
India's allopurinol export market is supplied by 223 active exporters who collectively shipped $492.9M across 4,362 shipments. IPCA LABORATORIES LIMITED leads with a 35.5% market share, followed by UNICHEM LABORATORIES LIMITED and INDOCO REMEDIES LIMITED. The top 5 suppliers together control 96.2% of total export value, reflecting a concentrated market structure.
Top Allopurinol Exporters from India — Ranked by Export Value
IPCA LABORATORIES LIMITED is the leading allopurinol exporter from India, holding a 35.5% share of the $492.9M market across 4,362 shipments from 223 exporters. The top 5 suppliers — IPCA LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, INDOCO REMEDIES LIMITED, SANDOZ PRIVATE LIMITED, PAR FORMULATIONS PRIVATE LIMITED — collectively control 96.2% of total export value, indicating a highly concentrated market. Individual shares are: IPCA LABORATORIES LIMITED (35.5%), UNICHEM LABORATORIES LIMITED (25.3%), INDOCO REMEDIES LIMITED (25.1%), SANDOZ PRIVATE LIMITED (5.9%), PAR FORMULATIONS PRIVATE LIMITED (4.4%).
Top Allopurinol Exporters from India
Ranked by export value · 223 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED HARMLESS MEDICINES IPCA-ALLOPURINOL 100MG TABLETS UNIT RATEHARMLESS MEDICINES IPCA-ALLOPURINOL 300MG TABLETS UNIT RATEALLOPURINOL 300MG TABLETS | $174.8M | 11 | 35.5% |
| 2 | UNICHEM LABORATORIES LIMITED ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $124.8M | 1 | 25.3% |
| 3 | INDOCO REMEDIES LIMITED ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAHARMLESS MEDICINES IPCA-ALLOPURINOL 100MG TABLETS UNIT RATEHARMLESS MEDICINES IPCA-ALLOPURINOL 300MG TABLETS UNIT RATE | $123.7M | 9 | 25.1% |
| 4 | SANDOZ PRIVATE LIMITED MATERIAL NO. - 42031699, ALLOPURINOL TAB300MG IN91 EU 01,ALLOPURINOL TAB 300MG IN91 SH EU 02 MATERIAL NO. - 42034619ALLOPURINOL TAB 300MG IN91 EU 01 MATERIA | $29.1M | 2 | 5.9% |
| 5 | PAR FORMULATIONS PRIVATE LIMITED ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $21.6M | 1 | 4.4% |
| 6 | HARMAN FINOCHEM LIMITED ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $3.4M | 4 | 0.7% |
| 7 | ZYDUS LIFESCIENCES LIMITED ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $2.7M | 1 | 0.5% |
| 8 | CAPLIN POINT LABORATORIES LIMITED | $1.6M | 6 | 0.3% |
| 9 | AUROBINDO PHARMA LTD HARMLESS MEDICINES ALLOPURINOL 100MG TABLETSALLOPURINOL100MG 2X14TACCORD-IRELANDALLOPURINOL 300MG 3X10TACO-NETHERLANDS | $1.2M | 2 | 0.3% |
| 10 | TORRENT PHARMACEUTICALS LTD ALLOPURINOL TABLETS 300MG ,PACK OF 10X1ALLOPURINOL TABLETS 100MG ,PACK OF 10X1ALLOPURINOL TABLETS 300MG EACH ALLOP | $1.2M | 4 | 0.2% |
| 11 | AUROBINDO PHARMA LIMITED HARMLESS MEDICINES ALLOPURINOL 100MG TABLETSALLOPURINOL100MG 2X14TACCORD-IRELANDALLOPURINOL 300MG 3X10TACO-NETHERLANDS | $1.2M | 3 | 0.2% |
| 12 | WATSON PHARMA PRIVATE LIMITED ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $971.9K | 1 | 0.2% |
| 13 | ADCOCK INGRAM LIMITED HARMLESS MEDICINES:ALLOPURINOL 300MG TABLETSALLOPURINOL TABLETS 100 MG CROSS SIONHARMLESS MEDICINES ALLOPURINOL 300MG T | $467.3K | 1 | 0.1% |
| 14 | CADILA HEALTHCARE LTD ALLOPURINOL TABLETS USP 300MG, EQUIVALENT TO- CYANO ACETAALLOPURINOL 300MG TAB 1000 - PO NO. - 45ALLOPURINOL 300MG TAB 500 - PO NO. - 450 | $455.0K | 1 | 0.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Allopurinol exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| IPCA LABORATORIES LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| UNICHEM LABORATORIES LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| INDOCO REMEDIES LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| SANDOZ PRIVATE LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| PAR FORMULATIONS PRIVATE LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| HARMAN FINOCHEM LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| ZYDUS LIFESCIENCES LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| CAPLIN POINT LABORATORIES LIMITED | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| AUROBINDO PHARMA LTD | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
| TORRENT PHARMACEUTICALS LTD | Approved | Yes | Yes | Not verified | FDA, WHO, and EU GMP certified. |
TransData Nexus reviewed the regulatory standing of 10 leading Allopurinol exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Allopurinol sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. This robust infrastructure and concentration of expertise make Hyderabad a strategic location for sourcing APIs such as Allopurinol.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Gujarat contributes nearly 28% of India's pharmaceutical production, with Ahmedabad and Vadodara being central to this output. The region is home to companies like Zydus Lifesciences Limited (formerly Cadila Healthcare Limited), which specializes in generic drugs and formulations. This concentration of formulation expertise positions the area as a key player in the production and export of finished pharmaceutical products, including Allopurinol.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being India's financial capital, hosts numerous pharmaceutical headquarters and benefits from extensive infrastructure that facilitates nationwide and international distribution. This region's strategic location and well-developed logistics make it an essential hub for exporting pharmaceutical products like Allopurinol to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh have emerged as significant pharmaceutical manufacturing zones, largely due to favorable tax incentives and government policies. Baddi, in particular, is recognized as Asia's largest pharmaceutical hub, housing over 1,000 pharmaceutical companies. The region's infrastructure and policy support have attracted numerous manufacturers, contributing substantially to India's pharmaceutical exports.
5Sourcing Recommendations
- Diversify Supplier Base: Given the high market concentration, consider engaging with multiple suppliers to mitigate risks associated with over-reliance on a few exporters.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of potential suppliers, focusing on those with a proven track record in Allopurinol production.
- Leverage Regional Strengths: Utilize the specific strengths of each pharmaceutical cluster—such as Hyderabad's API production and Ahmedabad-Vadodara's formulation expertise—to optimize sourcing strategies.
- Monitor Regulatory Compliance: Ensure that selected suppliers adhere to international regulatory standards, facilitating smoother export processes and market entry.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Allopurinol exporters from India
Ipca Laboratories Limited — Ipca Laboratories to acquire 33.38% stake in Unichem Laboratories
Ipca Laboratories announced a definitive Share Purchase Agreement to acquire 33.38% of Unichem Laboratories' equity shares at ₹440 per share, totaling ₹1,034.06 crores. An open offer for an additional 26% stake was also proposed. - IMPACT: This acquisition is expected to enhance Ipca's product portfolio and strengthen its position in the Allopurinol export market.
Impact: This acquisition is expected to enhance Ipca's product portfolio and strengthen its position in the Allopurinol export market.
Ipca Laboratories Limited — CCI approves Ipca's acquisition of 59.38% stake in Unichem Laboratories
The Competition Commission of India approved Ipca's acquisition of a 59.38% stake in Unichem Laboratories, subject to voluntary modifications, including Unichem's commitment not to re-enter the Indian formulations market for 36 months post-transaction. - IMPACT: Regulatory approval facilitates the consolidation, potentially increasing Allopurinol export capabilities.
Impact: Regulatory approval facilitates the consolidation, potentially increasing Allopurinol export capabilities.
Ipca Laboratories Limited — Ipca Laboratories invests in Unichem Laboratories
Ipca Laboratories completed its investment in Unichem Laboratories, aiming to enhance its product offerings and market reach. - IMPACT: The investment is likely to bolster Allopurinol production and export capacity.
Impact: The investment is likely to bolster Allopurinol production and export capacity.
Common Questions — Allopurinol Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which allopurinol supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, IPCA LABORATORIES LIMITED leads with 616 recorded shipments worth $174.8M. UNICHEM LABORATORIES LIMITED (444 shipments) and INDOCO REMEDIES LIMITED (682 shipments) are also established high-volume exporters.
Q How many allopurinol manufacturers are there in India?
India has 223 active allopurinol exporters with a combined export market of $492.9M across 4,362 shipments to 102 countries. The top 5 suppliers hold 96.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for allopurinol from India?
Average FOB unit price: $5.11 per unit, ranging from $0.00 to $2663.47. Average shipment value: $113.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 223 verified Indian exporters of Allopurinol ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,362 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 102 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,362 Verified Shipments
223 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists